These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17113605)

  • 1. Physiological and therapeutic factors affecting cholesterol metabolism: does a reciprocal relationship between cholesterol absorption and synthesis really exist?
    Santosa S; Varady KA; AbuMweis S; Jones PJ
    Life Sci; 2007 Jan; 80(6):505-14. PubMed ID: 17113605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption.
    Miettinen TA; Gylling H; Nissinen MJ
    Nutr Metab Cardiovasc Dis; 2011 Oct; 21(10):765-9. PubMed ID: 21899991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.
    Berthold HK; Laaksonen R; Lehtimäki T; Gylling H; Krone W; Gouni-Berthold I
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):262-7. PubMed ID: 18072016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol metabolism and body composition in women: the effects of moderate weight loss.
    Santosa S; Demonty I; Lichtenstein AH; Jones PJ
    Int J Obes (Lond); 2007 Jun; 31(6):933-41. PubMed ID: 17264848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of plant sterols and exercise training on cholesterol absorption and synthesis in previously sedentary hypercholesterolemic subjects.
    Varady KA; Houweling AH; Jones PJ
    Transl Res; 2007 Jan; 149(1):22-30. PubMed ID: 17196519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacologic elegance of inhibiting cholesterol absorption and synthesis while providing a homeostatic balance.
    Catapano AL
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():21-6. PubMed ID: 18001316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cholesterol absorption as a target for the treatment of hypercholesterolemia].
    Bitzur R; Cohen H; Harats D
    Harefuah; 2006 Nov; 145(11):831-5, 861, 860. PubMed ID: 17183957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline intestinal absorption and synthesis of cholesterol regulate its response to hypolipidaemic treatments in coronary patients.
    Gylling H; Miettinen TA
    Atherosclerosis; 2002 Feb; 160(2):477-81. PubMed ID: 11849674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol absorption and synthesis in children with type 1 diabetes.
    Järvisalo M; Raitakari O; Gylling H; Miettinen TA
    Diabetes Care; 2006 Oct; 29(10):2300-4. PubMed ID: 17003310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Distinction between good synthesizer and good absorber patients to optimize cholesterol-lowering therapy].
    Radermecker RP; Scheen AJ
    Rev Med Suisse; 2006 Aug; 2(76):1910-5. PubMed ID: 16972541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of quality of dietary fat on serum cholesterol and coronary heart disease: focus on plant sterols and other non-glyceride components.
    Ghafoorunissa
    Natl Med J India; 2009; 22(3):126-32. PubMed ID: 19764688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance.
    Pallebage-Gamarallage MM; Galloway S; Johnsen R; Jian L; Dhaliwal S; Mamo JC
    Br J Nutr; 2009 Feb; 101(3):340-7. PubMed ID: 18631412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dual inhibition of cholesterol using the drug combination ezetimibe/simvastatin?].
    Vaverková H
    Vnitr Lek; 2007 Apr; 53(4):421-7. PubMed ID: 17578178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS; Bissonnette S; Habib R; Boukas S;
    Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
    Piorkowski M; Fischer S; Stellbaum C; Jaster M; Martus P; Morguet AJ; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2007 Mar; 49(10):1035-42. PubMed ID: 17349882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin and ezetimibe combination therapy in cardiovascular disease.
    Dembowski E; Davidson MH
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):183-8. PubMed ID: 19262375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on patented cholesterol absorption inhibitors.
    Chhabria MT; Mahajan BM
    Expert Opin Ther Pat; 2009 Aug; 19(8):1083-107. PubMed ID: 19552506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of dyslipidemia in post-infarction: state of the art].
    Borgia MC; Nardi M; Da Ros S; Castellano V
    Clin Ter; 2007; 158(6):523-32. PubMed ID: 18265719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.